You searched for " retina"
All you need to know about PIC
This is a review article of punctate inner chorioretinopathy (PIC). The authors detail the epidemiology and clinic presentation of the disease. They recognise the challenge of an accurate diagnosis due to its resemblance to other posterior uveitic entities. Multimodal imaging...
Retinopathy of prematurity
This review article describes the pathophysiology of retinopathy of prematurity (ROP). The authors start by introducing the condition and its incidence. There is extensive information on the pathophysiology mechanisms involved in the condition to include normal and pathological retinal development....RCOphth (The Royal College of Ophthalmologists): Back to Basics - Byte sized topics for all
09:00 - 16:40 Join us for an immersive dive into the fascinating world of ophthalmology! Delve deep into the realm of red eyes as we uncover the hidden clues and learn to distinguish the subtle nuances that could signal danger. We'll embark on a journey through the intricate art of managing corneal ulcers, navigating the complexities of uveitis cases, and unravelling the mysteries behind disc swelling.Sense Medical and Canon: Getting ready for the OCT Pathway in Diabetic Eye Screening Surveillance Pathway webinar
Are you ready for the OCT pathway in DESP? OCT is set to be integrated into the English National Diabetic Eye Screening Surveillance Pathway, significantly enhancing the management of patients with mild diabetic maculopathy. This advancement allows patients to remain within a surveillance pathway overseen by retinal screening rather than being immediately referred to the Hospital Eye Service (HES). The webinar will be hosted by Professor Tunde Peto and Mrs Samantha Mann and will discuss the new OCT pathway, how OCT will change diabetic screening, how to interpret OCT images and how programmes can get ready for the change. Starts at 6pm UK time for 90 minutes
Visual acuity outcomes in Coat’s disease by classification stage
This is a retrospective study of 160 consecutive patients with Coat’s disease under the Shields classification, with Snellen visual acuity (VA) pre and post treatment. Affected eyes were categorised based on the Shields classification: Stage 1: retinal telangiectasia onlyStage 2a:...
Tumour deposits following choroidal melanoma treatment
The authors present the unique case of retinoinvasive melanoma following treatment of choroidal melanoma with brachytherapy. Uveal melanoma, the commonest intraocular malignancy in adults, presents as a pigmented mass in the choroid, ciliary body, or iris. A 79-year-old Caucasian male...
The effects of anti-VEGF therapy for NvAMD on retinal vasculature
This retrospective consecutive case series examined 54 eyes of 54 treatment-naïve neovascular age-related macular degeneration (N-AMD) patients. Thirty-three eyes received intravitreal aflibercept injections, and 21 eyes received intravitreal ranibizumab injections with unaffected fellow eyes (54 eyes) as controls. All image...
G-CSF intravitreal injections for NAION: a pilot study
In rodent models with anterior ischemic optic neuropathy (AION), granulocyte colony-stimulating factor (G-CSF) confers a neuroprotective effect on retinal ganglion cells (RGCs) via anti-apoptotic and anti-inflammatory processes. This prospective study investigated the efficacy of intravitreal injection of G-CSF for the...
FEVR characteristics
The authors report a series of 16 cases of familial exudative vitreoretinopathy (FEVR) in Northern Ireland (NI) to characterise the genetic patterns and identify other common characteristics relevant for current and future practice. This was a retrospective study including 12...SAVE THE DATE - Optos Peer Discussion Webinar
‘Working with ultra-widefield multi-modality retinal imaging: the clinical and practical value this technology adds to your ophthalmology clinic.’
Exploring the potential of neurodegenerative disease screening within age-related eye disease research
The authors recruited healthy controls aged between 60 and 75-years-old, previously enrolled into a registry as patients following cataract surgery without age-related macular degeneration (AMD). Exclusion criteria included dense cataract, retinal disease, ocular inflammatory disease, moderate glaucoma, optic neuropathy, cancer,...
